Calif. Inks Settlement With Endo Over Pay-For-Delay Scheme
Law360 (June 4, 2019, 11:37 PM EDT) -- Endo International PLC has promised to pay several hundred thousand dollars and agreed to a court order blocking the pharmaceutical company from engaging in certain business conduct in exchange for resolving claims of anticompetitive activity brought by California's attorney general.
Endo will pay California $760,000 and will be barred from entering into certain agreements with generic-drug makers intended to limit the generic makers' ability to develop or sell their competing products, according to a copy of the settlement agreement filed Tuesday in Golden State federal court.
The agreement will resolve claims related to an alleged pay-for-delay scheme involving the patent for...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!